comparemela.com

Latest Breaking News On - Celogics inc - Page 1 : comparemela.com

Global Induced Pluripotent Stem Cell (iPSC) Industry

Dublin, April 29, 2024 (GLOBE NEWSWIRE) The

United statesUnited kingdomHera biolabsAxol bioscienceNevia bioMasayo takahashiJames thomsonTakara bioShinya yamanakaAsia pacificExacis biotherapeuticsNeukio biotherapeuticsCellgenix gmbDrug developmentCentury therapeutics incCynata therapeutics ltd

Global Induced Pluripotent Stem Cell (iPSC) Industry Report 2023: Rapidly Growing Number of Studies Bodes Well for Sector

/PRNewswire/ The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, and Forecasts, 2023" report has been added to.

United kingdomJames thomsonTakara bioCellgenix gmbHera biolabsShinya yamanakaAxol bioscienceMasayo takahashiExacis biotherapeuticsNevia bioLaura woodResearch publicationsSelection of companiesAxol bioscience ltdAlstem incAstellas pharma inc

Global iPSCs Manufacturing Services Market Research Insight 2022| Industry Development - Future Growth Prospects, Revenue Forecast Up to 2030

Global iPSCs Manufacturing Services Market Research Insight 2022| Industry Development – Future Growth Prospects, Revenue Forecast Up to 2030

United statesNew zealandNova scotiaSouth africaSouth koreaAsia pacificBiotechnology companiesLonza groupAfrica ipscs manufacturing services marketResearch laboratories crosIpscs manufacturing services marketAxol bioscience ltdDrug development discoveryResearch newswireLatin america ipscs manufacturing services marketTakara bio inc

Global iPSCs Manufacturing Services Market Research Insight 2022

Global iPSCs Manufacturing Services Market Research Insight 2022

United statesNew zealandNova scotiaSouth africaSouth koreaAsia pacificBiotechnology companiesLonza groupAfrica ipscs manufacturing services marketResearch laboratories crosIpscs manufacturing services marketAxol bioscience ltdDrug development discoveryResearch newswireLatin america ipscs manufacturing services marketTakara bio inc

Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Vast Potential in Cell Therapy, Disease Modelling, Drug Development and Discovery, Personalized Medicine & Toxicology Testing

/PRNewswire/ The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report, 2022" report has been added to ResearchAndMarkets.com s offering. Since the.

Cellgenix gmbCatalent biologicsLaura woodResearch publicationsResearch within the overall stem cell industryAlstem incAxol bioscience ltdAstellas pharma incCelogics incPsc companiesAssignee organization typePsc researchAspen neuroscience incOffice hours callAms biotechnology ltdPscs in basic research

vimarsana © 2020. All Rights Reserved.